Emily Pimblett Eliem Therapeutics, Inc. (ELYM) insider trading activity

ELYM Quotes by TradingView

Emily Pimblett is CHIEF ACCOUNTING OFFICER of Eliem Therapeutics, Inc.. Currently has a direct ownership of 7,564 shares of ELYM, which is worth approximately $31,088. The most recent transaction as insider was on Sep 20, 2024, when has been sold 1,191 shares (Common Stock) at a price of $8.12 per share, resulting in proceeds of $9,670. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.56K
101.44% 3M change
n/a 12M change
Total Value Held $31,088

Emily Pimblett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2024
SELL
Open market or private sale
$9,670 $8.12 p/Share
1,191 Reduced 13.6%
7,564 Common Stock
Sep 18 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 36.35%
8,755 Common Stock
Jun 20 2024
SELL
Open market or private sale
$8,976 $7.21 p/Share
1,245 Reduced 24.9%
3,755 Common Stock
Jun 18 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 50.0%
5,000 Common Stock
EP

Emily Pimblett

CHIEF ACCOUNTING OFFICER
Wilmington, DE

Track Institutional and Insider Activities on ELYM

Follow Eliem Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

News

Receive news related to Eliem Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELYM